Lipoproteins in Diabetes Mellitus
Diabetes mellitus has become epidemic on a global scale, and millions of new cases are diagnosed every year. The epidemic of diabetes mellitus is expected to result in one of the steepest rises in human morbidity and mortality ever observed outside of wartime. Insulin resistance is a hallmark of pre...
Saved in:
| 企业作者: | |
|---|---|
| 其他作者: | , , |
| 格式: | 电子 电子书 |
| 语言: | English |
| 出版: |
New York, NY :
Springer New York : Imprint: Humana,
2014.
|
| 版: | 1st ed. 2014. |
| 丛编: | Contemporary Diabetes,
|
| 主题: | |
| 在线阅读: | https://doi.org/10.1007/978-1-4614-7554-5 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
书本目录:
- Laboratory Assessment of Lipoproteins in Diabetes
- Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin Resistance Diabetes
- Insulin Resistance and Atherosclerosis
- Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes
- Lipoprotein Metabolism and Alterations induced by insulin resistance and diabetes
- Production and Metabolism of Triglyceride-Rich Lipoproteins in both the Normal and Diabetic States
- Lipoprotein(a): Structure, Metabolism and Pathophysiology
- Lipoprotein Glycation in Diabetes Mellitus.-Lipoprotein (LDL and HDL) Oxidation in Diabetes Mellitus
- The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes
- Lipid – Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes
- Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus
- Endothelial Dysfunction and Dyslipidaemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy
- Lipoproteins and Diabetic Nephropathy
- Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy
- Effects of Lifestyle (Diet, Plant Sterols, Excercise) and Glycemic Control on Lipoporteins in Diabetes
- About Randomised Clinical Trials Related to Lipoproteins in Diabetes Mellitus
- Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients
- The PPAR System in Diabetes
- Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients
- Niacin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients
- Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus
- Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes.